# Standard Lithium LTD.: overview

SLI · NYSE · CIK 1537137 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sli.md) · [Financials](/companies/sli/financials.md) · [Filings](/companies/sli/filings.md) · [Insiders](/companies/sli/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

Not reported.

## Last five fiscal years

| Line item | Unit | FY (2024-06-30) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.59](/filings/0001193125-26-130448.md) | not reported | [(0.23)](/filings/0001193125-26-130448.md) |
| Free cash flow | $ | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare.
- Free cash flow (operating cash flow − capital expenditure). XBRL Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sli/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $43.8m | 15,935,383 |  | Reduced −2,846,967 |
| [Koch, Inc.](/funds/2027344.md) | 2026-06-30 | $37.1m | 13,480,083 |  | Unchanged |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $13.1m | 4,780,887 |  | New +4,780,887 |
| [Merewether Investment Management, LP](/funds/1736852.md) | 2026-06-30 | $11.2m | 4,057,435 |  | Added +85,039 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $5.9m | 2,157,881 |  | Reduced −484,665 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $5.9m | 2,146,398 |  | Added +301,199 |
| [TUDOR INVESTMENT CORP ET AL](/funds/923093.md) | 2026-06-30 | $5.5m | 2,013,385 |  | Added +237,963 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $4.9m | 1,779,889 |  | Added +33,108 |
| [Amundi](/funds/1330387.md) | 2026-06-30 | $4.9m | 1,776,555 |  | Reduced −3,000 |
| [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $3.6m | 1,312,578 |  | Added +133,709 |

## Recent filings

[All 226 filings](/companies/sli/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 20:50 ET | [6-K](/filings/0001104659-26-117441.md) | Report of a foreign private issuer, period 2026-10-20 | 0001104659-26-117441 |
| 2026-10-20 | 11:45 ET | [6-K](/filings/0001171843-26-006703.md) | Report of a foreign private issuer, period 2026-10-20 | 0001171843-26-006703 |
| 2026-10-16 | 10:05 ET | [6-K](/filings/0001104659-26-116374.md) | Report of a foreign private issuer, period 2026-10-16 | 0001104659-26-116374 |
| 2026-10-13 | 10:15 ET | [6-K](/filings/0001171843-26-006584.md) | Report of a foreign private issuer, period 2026-10-13 | 0001171843-26-006584 |
| 2026-10-09 | 20:49 ET | [6-K](/filings/0001193125-26-419189.md) | Report of a foreign private issuer, period 2026-10-09 | 0001193125-26-419189 |
| 2026-09-28 | 10:15 ET | [6-K](/filings/0001171843-26-006242.md) | Report of a foreign private issuer, period 2026-09-28 | 0001171843-26-006242 |
| 2026-09-21 | 21:09 ET | [6-K](/filings/0001104659-26-109361.md) | Report of a foreign private issuer, period 2026-09-21 | 0001104659-26-109361 |
| 2026-09-11 | 20:45 ET | [6-K](/filings/0001171843-26-006003.md) | Report of a foreign private issuer, period 2026-09-11 | 0001171843-26-006003 |
| 2026-09-10 | 21:03 ET | [6-K](/filings/0001104659-26-106754.md) | Report of a foreign private issuer, period 2026-09-10 | 0001104659-26-106754 |
| 2026-09-08 | 10:15 ET | [6-K](/filings/0001171843-26-005911.md) | Report of a foreign private issuer, period 2026-09-08 | 0001171843-26-005911 |

## Latest annual report

[Form 40-F for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-130448.md), filed Mar 30, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1537137
- Tickers: SLI
- Exchange: NYSE
- SIC code: 2800 Chemicals & Allied Products
- State of incorporation: A1
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.